Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ:: a nested case-control study

被引:256
|
作者
Ylitalo, N
Sorensen, P
Josefsson, AM
Magnusson, PKE
Andersen, PK
Pontén, J
Adami, HO
Gyllensten, UB
Melbye, M
机构
[1] Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden
[2] Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark
[3] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden
[4] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
[5] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA
[6] Harvard Univ, Harvard Ctr Canc Prevent, Boston, MA 02115 USA
来源
LANCET | 2000年 / 355卷 / 9222期
关键词
D O I
10.1016/S0140-6736(00)02402-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Persistent infection with certain types of human papillomavirus (HPV) is believed to be a prerequisite for the development of cervical neoplasia. Persistence may depend on certain characteristics, such as viral load, which has so far been given little attention. We investigated the association between HPV 16 viral load and cervical carcinoma in situ. Methods We did a nested case-control study of women participating in cytological screening in Sweden. We used a sensitive quantitative PCR assay to estimate HPV 16 load in multiple smears for each woman, taken during a period of up to 26 years before diagnosis. We calculated C-t values, which decrease as the number of viral DNA copies increases. Findings 2081 smears from 478 cases and 1754 smears from 608 controls were tested. Among cases, we found a consistently increased load of HPV 16 already 13 years or more before diagnosis, and when many smears were still cytologically normal. Women with high HPV 16 viral loads were at least 30 times the relative risk of HPV-16-negative women more than a decade before diagnosis. The increase in relative risk was constant over time. About 25% of women (95% CI 0.12-0.32) infected with a high viral load before age 25 years developed cervical carcinoma in situ within 15 years. Interpretation Cervical carcinoma in situ associated with HPV 16 occurs mainly in HPV-16-positive women who have consistently high viral loads long term. Women at high risk could be identified by use of a quantitative HPV test in addition to cytological screening.
引用
收藏
页码:2194 / 2198
页数:5
相关论文
共 50 条
  • [1] Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study
    Josefsson, AM
    Magnusson, PKE
    Ylitalo, N
    Sorensen, P
    Qwarforth-Tubbin, P
    Andersen, PK
    Melbye, M
    Adami, HO
    Gyllensten, UB
    LANCET, 2000, 355 (9222): : 2189 - 2193
  • [2] Viral Load in the Natural History of Human Papillomavirus Type 16 Infection: A Nested Case-control Study
    Xi, Long Fu
    Hughes, James P.
    Castle, Philip E.
    Edelstein, Zoe R.
    Wang, Chunhui
    Galloway, Denise A.
    Koutsky, Laura A.
    Kiviat, Nancy B.
    Schiffman, Mark
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (10): : 1425 - 1433
  • [3] Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: Nested case-control study
    Lehtinen, M
    Dillner, J
    Knekt, P
    Luostarinen, T
    Aromaa, A
    Kimbauer, R
    Koskela, P
    Paavonen, J
    Peto, R
    Schiller, JT
    Hakama, M
    BMJ-BRITISH MEDICAL JOURNAL, 1996, 312 (7030): : 537 - 539
  • [4] Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: A Nordic nested case-control study
    Korodi, Z
    Dillner, J
    Jellum, E
    Lumme, S
    Hallmans, G
    Thoresen, S
    Hakulinen, T
    Stattin, P
    Luostarinen, T
    Lehtinen, M
    Hakama, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (12) : 2952 - 2955
  • [5] Asian-American variants of human papillomavirus 16 and risk for cervical cancer:: a case-control study
    Berumen, J
    Ordoñez, RM
    Lazcano, E
    Salmeron, J
    Galvan, SC
    Estrada, RA
    Yunes, E
    Garcia-Carranca, A
    Madrigal-de la Campa, A
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (17): : 1325 - 1330
  • [6] High-risk HPVs and risk of cervical neoplasia: A nested case-control study
    Coker, AL
    Gerasimova, T
    King, MR
    Jackson, KL
    Pirisi, L
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2001, 70 (02) : 90 - 95
  • [7] Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case-control study
    Dong, Binhua
    Sun, Pengming
    Ruan, Guanyu
    Huang, Weiyi
    Mao, Xiaodan
    Kang, Yafang
    Pan, Diling
    Lin, Fen
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4839 - 4851
  • [8] Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study
    Zhang, Donghong
    Zhang, Qingying
    Zhou, Li
    Huo, Leijun
    Zhang, Yi
    Shen, Zhongying
    Zhu, Yi
    BMC CANCER, 2010, 10
  • [9] Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study
    Donghong Zhang
    Qingying Zhang
    Li Zhou
    Leijun Huo
    Yi Zhang
    Zhongying Shen
    Yi Zhu
    BMC Cancer, 10
  • [10] HUMAN PAPILLOMAVIRUS AND CERVICAL NEOPLASIA - A CASE-CONTROL STUDY IN TAIWAN
    LIAW, KL
    HSING, AW
    CHEN, CJ
    SCHIFFMAN, MH
    ZHANG, TY
    HSIEH, CY
    GREER, CE
    YOU, SL
    HUANG, TW
    WU, TC
    OLEARY, TJ
    SEIDMAN, JD
    BLOT, WJ
    MEINERT, CL
    MANOS, MM
    INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (05) : 565 - 571